Articles
Why Patient-Reported Outcomes are Rarely Used in Trials, and How We Change That
If drug developers design trials to measure how well their drug addresses the issues most important to the target patient community, we could expect to end up with better drugs. Integrating patient-reported outcomes into clinical trials is the way to…
A Promise Kept: How Samvel Danielyan Lifted Pediatric Cancer Survival from Zero to 70%
In a country bruised by war, in a hospital crumbling under the weight of poverty and silence, one man made an impossible promise and kept it. Samvel Danielyan’s story is not the story of easy heroes. It is a story…
Together, She Changed Everything: Martine Piccart ’s Fight Against Breast Cancer
Prof. Martine Piccart grew up in a house where medicine was part of the air. Her father, a gynecologist, treated patients at home. “I admired him deeply,” she says. “He helped people. I saw that up close. It left a…
A Vision for Cancer Policy in Europe: An Interview with MEP Nikos Papandreou
CancerWorld had the opportunity to interview Nikos Papandreou, Member of the European Parliament and a dedicated advocate for cancer policy reform. With a background in politics, economics, and healthcare policy, Mr. Papandreou has been at the forefront of tackling Europe’s…
(Re)Thinking Psycho-oncology in a world out of balance: What I learned after a year of interviews
"One must imagine Sisyphus happy" Albert Camus Why me? This is probably the present-day question of every patient with cancer! One of the consequences of our chaotic reality is cancer, which belongs to that class of diseases that impacts the…
CancerWorld issue #103 (May, 2025)
What does it take to change the odds in cancer care? Innovation? Yes. But also: persistence. Collaboration. The refusal to accept that some lives matter less because of where they’re born. In this issue of CancerWorld, we focus not just…
Adrian Gottschalk: Making a Difference for His Fellow Human Beings
I grew up around a lot of physicians,” begins Adrian Gottschalk, President and CEO of Foghorn Therapeutics, a biotech company redefining how we understand and treat complex diseases by targeting the chromatin regulatory system. “My late father was a professor…
ACT for Children:A Global Initiative to Tackle Inequities in Pediatric Cancer
The disparity in childhood cancer outcomes is one of the world’s most pressing health inequities. While over 80% of children with cancer are cured in high-income countries (HICs), survival drops to less than 30% in low- and middle-income countries (LMICs).…
Miriam Merad and the 2025 Sjöberg Prize: A Celebration of Innovation in Cancer Immunotherapy
Every year, the Sjöberg Prize, established by the Royal Swedish Academy of Sciences, honors researchers whose scientific discoveries in oncology are reshaping the understanding and treatment of cancer. The award stands alongside the most prestigious accolades in science, not only…
“I really care about people.” – Philip Kantoff, A Life in Science and Medicine
“I wanted to be a scientist when I grew up.” Boston. The city where old bricks and new ideas stand side by side. Where science, education, and innovation breathe together. The wind cuts through the streets of New England, sharp…